Anzeige
Mehr »
Dienstag, 16.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0DLB7 | ISIN: CA88337V1004 | Ticker-Symbol: TTX
Frankfurt
16.09.25 | 08:00
0,101 Euro
-0,98 % -0,001
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
THERALASE TECHNOLOGIES INC Chart 1 Jahr
5-Tage-Chart
THERALASE TECHNOLOGIES INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0980,13011:39

Aktuelle News zur THERALASE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
02.09.Theralase Technologies Inc: Theralase Technologies 1.84 million warrants extended2
02.09.Theralase Technologies is very undervalued, this analyst says1
30.08.Theralase Technologies Inc: Theralase to extend expiry of 1.84M warrants to 20282
29.08.Theralase Technologies Inc.: Theralase(R) Extends Warrants502Toronto, Ontario--(Newsfile Corp. - August 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
26.08.Theralase Technologies Inc.: Theralase(R) Releases 2Q2025 Financial Statements392Toronto, Ontario--(Newsfile Corp. - August 26, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical pioneering light, radiation...
► Artikel lesen
01.08.Theralase Technologies Inc: Theralase 3,363,134-share private placement2
THERALASE Aktie jetzt für 0€ handeln
28.07.Theralase Technologies Inc: Theralase Technologies closes $672,727 financing3
28.07.Theralase Technologies Inc.: Theralase(R) Closes Non-Brokered Private Placement217Toronto, Ontario--(Newsfile Corp. - July 28, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
28.06.Theralase Technologies Inc: Theralase to extend warrant expiry by three years1
27.06.Theralase Technologies Inc.: Theralase(R) Extends Warrants509Toronto, Ontario--(Newsfile Corp. - June 27, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
18.06.Theralase Technologies Inc: Theralase 2,885,000-share private placement1
17.06.Theralase Technologies Inc: Theralase closes $571,000 private placement4
17.06.Theralase Technologies Inc.: Theralase(R) Closes Non-Brokered Private Placement246Toronto, Ontario--(Newsfile Corp. - June 17, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
12.06.Theralase Technologies Inc: Theralase completes AGSM1
12.06.Theralase Technologies Inc.: Theralase Completes Annual General and Special Meeting255Toronto, Ontario--(Newsfile Corp. - June 12, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
09.06.Earnings Call Transkript: Theralase Technologies verfehlt EPS im Q1 2025, Aktie fällt4
05.06.Theralase Technologies Inc: Theralase to hold AGSM June 114
05.06.Theralase Technologies Inc.: Theralase Annual General Meeting436Toronto, Ontario--(Newsfile Corp. - June 5, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
30.05.Theralase Technologies Inc.: Theralase(R) 1Q2025 Financial Statements455Toronto, Ontario--(Newsfile Corp. - May 30, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
29.05.Theralase Technologies Inc.: Theralase to Present Groundbreaking Research at ASTRO 2025532Toronto, Ontario--(Newsfile Corp. - May 29, 2025) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company pioneering light...
► Artikel lesen
Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1